Transdermal Electroacupuncture for Opioid Detoxification

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

January 31, 2010

Conditions
Opioid Dependency
Interventions
DEVICE

Electroacupuncture

Participants are randomly assigned to receive either active or sham electroacupuncture using the Han's Acupoint Nerve Stimulator (HANS) device. The HANS method uses a non-invasive device that emits a constant electric current transcutaneously via skin electrodes to stimulate relevant acupoints: Heku (LI4) / Laogong (P8) on one hand and Neiguan (P6) / Waiguan (TE 5) on the opposite arm. Stimulation is delivered in the dense-and-disperse mode, alternating between 2 and 100 Hz at 3-second intervals. Participants receive thrice daily treatments for 4 days during inpatient opioid detoxification.

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

Harvard Medical School (HMS and HSDM)

OTHER

lead

Mclean Hospital

OTHER

NCT00742170 - Transdermal Electroacupuncture for Opioid Detoxification | Biotech Hunter | Biotech Hunter